65
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Immunosuppressants and new onset gallstone disease in patients having undergone renal transplantation

, , &
Pages 1391-1398 | Published online: 13 Oct 2017

References

  • ChenCHHuangMHYangJCPrevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological surveyJ Gastroenterol Hepatol200621111737174316984599
  • AhmedACheungRCKeeffeEBManagement of gallstones and their complicationsAm Fam Physician2000616167316801687168810750875
  • HuangJChangCHWangJLNationwide epidemiological study of severe gallstone disease in TaiwanBMC Gastroenterol20099637219698126
  • BeckinghamIJABC of diseases of liver, pancreas, and biliary system. Gallstone diseaseBMJ2001322919411154626
  • BiddingerSBHaasJTYuBBHepatic insulin resistance directly promotes formation of cholesterol gallstonesNat Med200814777878218587407
  • PauletzkiJAlthausRHollJSackmannMPaumgartnerGGallbladder emptying and gallstone formation: a prospective study on gallstone recurrenceGastroenterology199611137657718780583
  • GladziwaUWagnerSKockRMannHSieberthHGSonographic evaluation of gallbladder motility in patients with end-stage renal disease on haemodialysisNephrol Dial Transplant1992788408431325618
  • van PetersenASvan der PijlHWRingersJLemkesHHde FijterHWMascleeAAGallstone formation after pancreas and/or kidney transplantation: an analysis of risk factorsClin Transplant200721565165817845641
  • SarkioSSalmelaKKyllonenLRosliakovaMHonkanenEHalmeLComplications of gallstone disease in kidney transplantation patientsNephrol Dial Transplant200722388689017205965
  • AlberuJGaticaMCachafeiro-VilarMAsymptomatic gallstones and duration of cyclosporine use in kidney transplant recipientsRev Invest Clin200153539640011795104
  • StiefJStempfleHUGotzbergerMBiliary disease in heart transplanted patients: a comparison between cyclosporine A versus tacrolimus-based immunosuppressionEur J Med Res20091420620919541577
  • European Expert Group on Renal TransplantationEuropean best practice guidelines for renal transplantation (part 1)Nephrol Dial Transplant200015suppl 7185
  • KaoLSKuhrCSFlumDRShould cholecystectomy be performed for asymptomatic cholelithiasis in transplant patients?J Am Coll Surg200319730231212892816
  • MekaMPotdarSBenottiPHartleJESenkowskiCRole of ultrasound screening for gallbladder disease in pretransplant patientsAm Surg200874983283318807672
  • ParkSHHahmJSSeongSSIncidence of gallbladder stones in renal transplant recipientsKorean J Gastroenterol200444424615266132
  • ChenCYLuCLHuangYSAge is one of the risk factors in developing gallstone disease in TaiwanAge Ageing19982744374419883999
  • LaiSWNgKCRisk factors for gallstone disease in a hospital-based studySouth Med J200295121419142312597310
  • LaiS-WLiaoK-FLaiH-CChouC-YChengK-CLaiY-MThe prevalence of gallbladder stones is higher among patients with chronic kidney disease in TaiwanMedicine2009881465119352299
  • ChenJYHsuCTLiuJHTungTHClinical predictors of incident gallstone disease in a Chinese population in Taipei, TaiwanBMC Gastroenterol2014148324775330
  • KadmonMKlunemannCBohmeMInhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bileGastroenterology19931045150715147683296
  • ChanussotFBotta-FridlundDLechene de la PortePEffects of cyclosporine and corticosteroids on bile secretion in the ratTransplantation19925422262311496534
  • MizutaKKobayashiEUchidaHFujimuraAKawarasakiHHashizumeKInfluence of tacrolimus on bile acid and lipid composition in continuously drained bile using a rat model. Comparative study with cyclosporineTranspl Int199912531632210551996
  • MizutaKKobayashiEUchidaHHishikawaSKawarasakiHIncrease of bile acid production by tacrolimus in the rat liverTransplant Proc20033543743812591477
  • AlmeidaCSilveiraMde AraújoVSafety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysisPharmaceuticals (Basel)20136101170119424275847
  • NankivellBJP’NgCHO’ConnellPJChapmanJRCalcineurin inhibitor nephrotoxicity through the lens of longitudinal histologyTransplantation20161001723173127306529
  • ZazaGTomeiPRiaPGranataSBoschieroLLupoASystemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitorsClin Dev Immunol2013201340328024151517
  • LimWHErisJKanellisJA systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipientsAm J Transplant20141492106211925088685
  • TakeyamaHSinananMNFishbeinDPAldeaGSVerrierEDSalernoCTExpectant management is safe for cholelithiasis after heart transplantJ Heart Lung Transplant200625553954316678032